glp-1 drugs and alcohol consumption receptor agonists may protect the liver during GLP-1 Anti-Obesity Rx and Alcohol
Description
GI adverse events not infrequently lead to discontinuation of drug treatment, both in randomized clinical trials (16, 17) and in real-world practice (18, 19)
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Glucocorticoid-Induced Osteoporosis Glucocorticoid (GC) treatment is the main cause of secondary osteoporosis
Dan Med J
Kawai Y, Uneda K, Yamada T, et al
Contrast, resistance to extinction, and forgetting in rats
Long-term strategy: Weight regain after stopping GLP-1s is well-documented
